Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

Cardiomyocytes disrupt pyrimidine biosynthesis in nonmyocytes to regulate heart repair.

  • Author(s): Li, Shen;
  • Yokota, Tomohiro;
  • Wang, Ping;
  • Ten Hoeve, Johanna;
  • Ma, Feiyang;
  • Le, Thuc M;
  • Abt, Evan R;
  • Zhou, Yonggang;
  • Wu, Rimao;
  • Nanthavongdouangsy, Maxine;
  • Rodriguez, Abraham;
  • Wang, Yijie;
  • Lin, Yen-Ju;
  • Muranaka, Hayato;
  • Sharpley, Mark;
  • Braddock, Demetrios T;
  • MacRae, Vicky E;
  • Banerjee, Utpal;
  • Chiou, Pei-Yu;
  • Seldin, Marcus;
  • Huang, Dian;
  • Teitell, Michael;
  • Gertsman, Ilya;
  • Jung, Michael;
  • Bensinger, Steven J;
  • Damoiseaux, Robert;
  • Faull, Kym;
  • Pellegrini, Matteo;
  • Lusis, Aldons J;
  • Graeber, Thomas G;
  • Radu, Caius G;
  • Deb, Arjun
  • et al.

Published Web Location

https://doi.org/10.1172/jci149711
Abstract

Various populations of cells are recruited to the heart after cardiac injury, but little is known about whether cardiomyocytes directly regulate heart repair. Using a murine model of ischemic cardiac injury, we demonstrate that cardiomyocytes play a pivotal role in heart repair by regulating nucleotide metabolism and fates of nonmyocytes. Cardiac injury induced the expression of the ectonucleotidase ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), which hydrolyzes extracellular ATP to form AMP. In response to AMP, cardiomyocytes released adenine and specific ribonucleosides that disrupted pyrimidine biosynthesis at the orotidine monophosphate (OMP) synthesis step and induced genotoxic stress and p53-mediated cell death of cycling nonmyocytes. As nonmyocytes are critical for heart repair, we showed that rescue of pyrimidine biosynthesis by administration of uridine or by genetic targeting of the ENPP1/AMP pathway enhanced repair after cardiac injury. We identified ENPP1 inhibitors using small molecule screening and showed that systemic administration of an ENPP1 inhibitor after heart injury rescued pyrimidine biosynthesis in nonmyocyte cells and augmented cardiac repair and postinfarct heart function. These observations demonstrate that the cardiac muscle cell regulates pyrimidine metabolism in nonmuscle cells by releasing adenine and specific nucleosides after heart injury and provide insight into how intercellular regulation of pyrimidine biosynthesis can be targeted and monitored for augmenting tissue repair.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View